Cargando…

Design of a treatment pathway for insomnia in prison settings in England: a modified Delphi study

OBJECTIVE: Insomnia is highly prevalent in prisoners and is a risk factor for poor mental well-being, depression, suicidality and aggression, all common concerns in this vulnerable population. Improving sleep management options in prison offers the potential to impact positively on a number of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewa, Lindsay H, Hassan, Lamiece, Shaw, Jenny, Senior, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119453/
https://www.ncbi.nlm.nih.gov/pubmed/30158230
http://dx.doi.org/10.1136/bmjopen-2018-022406
_version_ 1783352088570363904
author Dewa, Lindsay H
Hassan, Lamiece
Shaw, Jenny
Senior, Jane
author_facet Dewa, Lindsay H
Hassan, Lamiece
Shaw, Jenny
Senior, Jane
author_sort Dewa, Lindsay H
collection PubMed
description OBJECTIVE: Insomnia is highly prevalent in prisoners and is a risk factor for poor mental well-being, depression, suicidality and aggression, all common concerns in this vulnerable population. Improving sleep management options in prison offers the potential to impact positively on a number of these common risk factors. The study aim was to design a treatment pathway for insomnia in prisons informed by stakeholders with professional or lived experience of insomnia and prison-based interventions. DESIGN: A modified Delphi technique, adapted to the stakeholder (either receiving controlled feedback online or face to face on a series of statements), was used over three rounds to gain consensus on a final treatment pathway design. PARTICIPANTS: Academic sleep researchers, prison staff and prisoners were invited to develop the treatment pathway. RESULTS: Fifteen stakeholders took part in round 1 and thirteen in round 2. There were six statements of contention that comprised concerns over the inclusion of sleep observations, sleep restriction therapy and promethazine. Consensus was high (>80%). Thirteen stakeholders agreed the final pathway in round 3. The final treatment pathway comprised a standardised stepped-care approach for insomnia in prison populations. The pathway resulted in five main stages: (1) transition from community; (2) detection and assessment; (3) treatment for short-term insomnia; (4) treatment for long-term insomnia and (5) transition from prison to community or another establishment. CONCLUSIONS: The treatment pathway is designed to promote early detection of insomnia, potentially reducing unnecessary prescriptions and medication trading, misuse and diversion in the prison setting. It should make a substantial difference in reducing the large number of sleep complaints and positively impact on prisoners, staff and the prison environment. Specifically, improving sleep should have a positive impact on prisoners’ mental and physical well-being and aid smooth running of the prison.
format Online
Article
Text
id pubmed-6119453
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-61194532018-09-04 Design of a treatment pathway for insomnia in prison settings in England: a modified Delphi study Dewa, Lindsay H Hassan, Lamiece Shaw, Jenny Senior, Jane BMJ Open Mental Health OBJECTIVE: Insomnia is highly prevalent in prisoners and is a risk factor for poor mental well-being, depression, suicidality and aggression, all common concerns in this vulnerable population. Improving sleep management options in prison offers the potential to impact positively on a number of these common risk factors. The study aim was to design a treatment pathway for insomnia in prisons informed by stakeholders with professional or lived experience of insomnia and prison-based interventions. DESIGN: A modified Delphi technique, adapted to the stakeholder (either receiving controlled feedback online or face to face on a series of statements), was used over three rounds to gain consensus on a final treatment pathway design. PARTICIPANTS: Academic sleep researchers, prison staff and prisoners were invited to develop the treatment pathway. RESULTS: Fifteen stakeholders took part in round 1 and thirteen in round 2. There were six statements of contention that comprised concerns over the inclusion of sleep observations, sleep restriction therapy and promethazine. Consensus was high (>80%). Thirteen stakeholders agreed the final pathway in round 3. The final treatment pathway comprised a standardised stepped-care approach for insomnia in prison populations. The pathway resulted in five main stages: (1) transition from community; (2) detection and assessment; (3) treatment for short-term insomnia; (4) treatment for long-term insomnia and (5) transition from prison to community or another establishment. CONCLUSIONS: The treatment pathway is designed to promote early detection of insomnia, potentially reducing unnecessary prescriptions and medication trading, misuse and diversion in the prison setting. It should make a substantial difference in reducing the large number of sleep complaints and positively impact on prisoners, staff and the prison environment. Specifically, improving sleep should have a positive impact on prisoners’ mental and physical well-being and aid smooth running of the prison. BMJ Publishing Group 2018-08-29 /pmc/articles/PMC6119453/ /pubmed/30158230 http://dx.doi.org/10.1136/bmjopen-2018-022406 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Mental Health
Dewa, Lindsay H
Hassan, Lamiece
Shaw, Jenny
Senior, Jane
Design of a treatment pathway for insomnia in prison settings in England: a modified Delphi study
title Design of a treatment pathway for insomnia in prison settings in England: a modified Delphi study
title_full Design of a treatment pathway for insomnia in prison settings in England: a modified Delphi study
title_fullStr Design of a treatment pathway for insomnia in prison settings in England: a modified Delphi study
title_full_unstemmed Design of a treatment pathway for insomnia in prison settings in England: a modified Delphi study
title_short Design of a treatment pathway for insomnia in prison settings in England: a modified Delphi study
title_sort design of a treatment pathway for insomnia in prison settings in england: a modified delphi study
topic Mental Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119453/
https://www.ncbi.nlm.nih.gov/pubmed/30158230
http://dx.doi.org/10.1136/bmjopen-2018-022406
work_keys_str_mv AT dewalindsayh designofatreatmentpathwayforinsomniainprisonsettingsinenglandamodifieddelphistudy
AT hassanlamiece designofatreatmentpathwayforinsomniainprisonsettingsinenglandamodifieddelphistudy
AT shawjenny designofatreatmentpathwayforinsomniainprisonsettingsinenglandamodifieddelphistudy
AT seniorjane designofatreatmentpathwayforinsomniainprisonsettingsinenglandamodifieddelphistudy